← Back
$VKTX All transactions

Viking Therapeutics, Inc.

A

$ Value

$0

Shares

11,117

Price

$0

Filed

Oct 28

Insider

Name

ZANTE GREG

Title

Chief Financial Officer

CIK

0001264949

Roles

Officer

Transaction Details

Transaction Date

2025-10-27

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

179,777

Footnotes

The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on October 27, 2025 upon the achievement of a non-financial performance goal and 15% of which vested also on October 27, 2025 upon the partial achievement of a non-financial performance goal. | These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.6525 to $35.3939, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote.

Filing Info

Accession No.

0001193125-25-254298

Form Type

4

Issuer CIK

0001607678

ZANTE GREG's History

Date Ticker Type Value
2026-01-05 VKTX $1.0M
2026-01-05 VKTX $464K
2026-01-05 VKTX $353K
2026-01-05 VKTX $48K
2026-01-02 VKTX A $0
2026-01-02 VKTX A $0
2026-01-02 VKTX A $0
2025-10-28 VKTX $216K
2025-10-27 VKTX A $0
2025-07-03 VKTX $118K

Other Insiders at VKTX (90d)

Insider Bought Sold Last
Aubuchon Neil William
Chief Commercial Officer
$150K 2026-03-10